Luke Sergott Analyst Performance

Director at Barclays

Luke Sergott is a stock analyst at Barclays focused in the medical sector, covering 25 publicly traded companies. Over the past year, Luke Sergott has issued 56 stock ratings, including buy, hold, and sell recommendations. While full access to Luke Sergott's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Luke Sergott's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Analyst Ranking

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

58 Last 5 Years

Buy Recommendations

56.90% 33 Buy Ratings

Companies Covered

25 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	56.9%	33 ratings
Hold	37.9%	22 ratings
Sell	5.2%	3 ratings

Out of 58 total stock ratings issued by Luke Sergott at Barclays, the majority (56.9%) have been Buy recommendations, followed by 37.9% Hold and 5.2% Sell.

Best & Worst Calls

• Best Call

  000.0%

  TXG

  Dec 2019

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.
• Worst Call

  000.0%

  TWST

  Feb 2020

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	60.0% of companies on NASDAQ	15 companies
NYSE	40.0% of companies on NYSE	10 companies

Luke Sergott, an analyst at Barclays, currently covers 25 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 24 companies	96.0%
	Computer and Technology 1 company	4.0%

Luke Sergott of Barclays specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology companies.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 9 companies	36.0%
MEDICAL SERVICES 7 companies	28.0%
MED INSTRUMENTS 5 companies	20.0%
MED PRODUCTS 1 company	4.0%
MEDICAL INFO SYS 1 company	4.0%
INSTRU - SCIENTFC 1 company	4.0%
MED/DENTAL - SUPP 1 company	4.0%

About Luke Sergott

Experienced healthcare analyst with a focus in public and private Life Sciences and Diagnostics companies.

Follow on LinkedIn

Luke Sergott's Ratings History at Barclays

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
TMO Thermo Fisher Scientific	9/11/2025	Upgrade	$477.03	$550.00	Overweight	$0.00 00.00% ROI
A Agilent Technologies	8/29/2025	Reiterated Rating	$124.70	$125.00	Equal Weight	$0.00 00.00% ROI
NTRA Natera	8/8/2025	Reiterated Rating	$141.08	$210.00	Overweight	$0.00 00.00% ROI
TXG 10x Genomics	8/8/2025	Reiterated Rating	$12.80	$15.00	Overweight	$0.00 00.00% ROI
FTRE Fortrea	8/7/2025	Reiterated Rating	$6.58	$6.00	Underweight	$0.00 00.00% ROI
EXAS Exact Sciences	8/7/2025	Lower Price Target	$46.91	$55.00	Overweight	$0.00 00.00% ROI
CRL Charles River Laboratories International	8/7/2025	Boost Price Target	$150.60	$165.00	Equal Weight	$0.00 00.00% ROI
AVTR Avantor	8/4/2025	Reiterated Rating	$11.46	$13.00	Overweight	$0.00 00.00% ROI
BRKR Bruker	8/4/2025	Lower Price Target	$34.72	$43.00	Overweight	$0.00 00.00% ROI
INCY Incyte	8/1/2025	Initiated Coverage	$74.89	$90.00	Overweight	$0.00 00.00% ROI
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ILMN Illumina	8/1/2025	Boost Price Target	$97.65	$90.00	Underweight	$0.00 00.00% ROI
ICLR Icon	7/25/2025	Boost Price Target	$186.16	$180.00	Equal Weight	$0.00 00.00% ROI
TMO Thermo Fisher Scientific	7/24/2025	Boost Price Target	$466.84	$490.00	Equal Weight	$0.00 00.00% ROI
MEDP Medpace	7/23/2025	Boost Price Target	$477.73	$450.00	Equal Weight	$0.00 00.00% ROI
IQV IQVIA	7/23/2025	Boost Price Target	$187.89	$185.00	Equal Weight	$0.00 00.00% ROI
PACB Pacific Biosciences of California	6/25/2025	Lower Price Target	$1.18	$1.50	Equal Weight	$0.00 00.00% ROI
MEDP Medpace	6/24/2025	Initiated Coverage	$308.64	$300.00	Equal Weight	$0.00 00.00% ROI
MTD Mettler-Toledo International	6/24/2025	Initiated Coverage	$1,164.53	$1,325.00	Overweight	$0.00 00.00% ROI
QGEN Qiagen	6/24/2025	Initiated Coverage	$46.72	$55.00	Overweight	$0.00 00.00% ROI
RGEN Repligen	6/24/2025	Initiated Coverage	$120.11	$150.00	Overweight	$0.00 00.00% ROI
WST West Pharmaceutical Services	6/24/2025	Initiated Coverage	$217.05	$245.00	Equal Weight	$0.00 00.00% ROI
TXG 10x Genomics	6/24/2025	Reiterated Rating	$10.94	$13.00	Overweight	$0.00 00.00% ROI
TMO Thermo Fisher Scientific	6/24/2025	Lower Price Target	$401.19	$450.00	Equal Weight	$0.00 00.00% ROI
SHC Sotera Health	6/24/2025	Lower Price Target	$11.20	$13.00	Overweight	$0.00 00.00% ROI
CERT Certara	5/8/2025	Upgrade	$11.46	$14.00	Overweight	$0.00 00.00% ROI
CRL Charles River Laboratories International	5/8/2025	Boost Price Target	$141.77	$155.00	Equal Weight	$0.00 00.00% ROI
BRKR Bruker	5/8/2025	Lower Price Target	$42.13	$46.00	Overweight	$0.00 00.00% ROI
AVTR Avantor	4/28/2025	Lower Price Target	$12.93	$15.00	Overweight	$0.00 00.00% ROI
IQV IQVIA	4/10/2025	Reiterated Rating	$157.02	$170.00	Equal Weight	$0.00 00.00% ROI
ICLR Icon	4/10/2025	Reiterated Rating	$155.49	$165.00	Equal Weight	$0.00 00.00% ROI
FTRE Fortrea	4/10/2025	Reiterated Rating	$6.45	$6.00	Underweight	$0.00 00.00% ROI
DHR Danaher	4/10/2025	Upgrade	$192.18	$205.00	Overweight	$0.00 00.00% ROI
CRL Charles River Laboratories International	4/10/2025	Lower Price Target	$128.77	$145.00	Equal Weight	$0.00 00.00% ROI
CERT Certara	4/10/2025	Lower Price Target	$9.02	$11.00	Equal Weight	$0.00 00.00% ROI
AVTR Avantor	4/10/2025	Lower Price Target	$14.97	$18.00	Overweight	$0.00 00.00% ROI
TXG 10x Genomics	4/10/2025	Lower Price Target	$7.81	$12.00	Overweight	$0.00 00.00% ROI
TWST Twist Bioscience	4/10/2025	Lower Price Target	$35.90	$45.00	Overweight	$0.00 00.00% ROI
TMO Thermo Fisher Scientific	4/10/2025	Lower Price Target	$424.64	$475.00	Equal Weight	$0.00 00.00% ROI
SHC Sotera Health	4/10/2025	Lower Price Target	$10.61	$12.00	Overweight	$0.00 00.00% ROI
FTRE Fortrea	3/4/2025	Lower Price Target	$10.38	$12.00	Equal Weight	$0.00 00.00% ROI
CERT Certara	2/28/2025	Boost Price Target	$11.87	$13.00	Equal Weight	$0.00 00.00% ROI
SHC Sotera Health	2/28/2025	Lower Price Target	$12.47	$16.00	Overweight	$0.00 00.00% ROI
ICLR Icon	2/21/2025	Lower Price Target	$201.84	$240.00	Overweight	$0.00 00.00% ROI
SHC Sotera Health	2/18/2025	Lower Price Target	$13.48	$17.00	Overweight	$0.00 00.00% ROI
CRL Charles River Laboratories International	2/18/2025	Lower Price Target	$152.07	$166.00	Equal Weight	$0.00 00.00% ROI
A Agilent Technologies	2/10/2025	Upgrade	$145.21	$145.00	Equal Weight	$0.00 00.00% ROI
WAT Waters	2/10/2025	Upgrade	$408.96	$415.00	Equal Weight	$0.00 00.00% ROI
AVTR Avantor	2/10/2025	Lower Price Target	$19.15	$23.00	Overweight	$0.00 00.00% ROI
TXG 10x Genomics	2/10/2025	Lower Price Target	$14.25	$18.00	Overweight	$0.00 00.00% ROI
TWST Twist Bioscience	2/3/2025	Set Price Target	$41.31	$58.00	Overweight	$0.00 00.00% ROI
AVTR Avantor	2/3/2025	Boost Price Target	$22.15	$26.00	Overweight	$0.00 00.00% ROI
IQV IQVIA	2/3/2025	Lower Price Target	$200.31	$235.00	Overweight	$0.00 00.00% ROI
DHR Danaher	1/30/2025	Lower Price Target	$223.12	$240.00	Equal Weight	$0.00 00.00% ROI
EXAS Exact Sciences	1/23/2025	Initiated Coverage	$54.79	$70.00	Overweight	$0.00 00.00% ROI
GH Guardant Health	1/23/2025	Initiated Coverage	$47.20	$60.00	Overweight	$0.00 00.00% ROI
NTRA Natera	1/23/2025	Initiated Coverage	$171.93	$200.00	Overweight	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.